Immunstimulating lipid formulation
US7128909B2 · kind B2 · utility
1Cited by
8References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 9, 1997 |
| Grant date | Oct 31, 2006 |
| Priority date | — |
| Expiry date | Jun 9, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16151
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation for parenteral or mucosal administration of antigens and/or vaccines to humans and animals, comprising monoglyceride preparations having at least 80% monoglyceride content and where the acyl group contains from 6 to 24 carbon atoms, together with fatty acids where the number of carbon atoms may be varied between 4 and 22.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.